<DOC>
	<DOC>NCT02324595</DOC>
	<brief_summary>Phase II multicentric study</brief_summary>
	<brief_title>Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study</brief_title>
	<detailed_description>The aim of this prospective Phase II multicentric study is to assess feasibility and early complications rate of "total laparoscopic/robotic" interval debulking surgery in patients with a clinical complete/partial response to neoadjuvant chemotherapy for advanced ovarian cancer.</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Age &gt;18 years, Advanced ovarian cancer submitted to neoadjuvant chemotherapy, Clinical or serological complete/partial response (RECIST; GCIG), PS â‰¤ 2 (ECOG), Informed consent Borderline and nonepithelial ovarian tumors, Stable/progressive disease, ASA 34, Severe cardiopulmonary disease, BMI &gt; 40</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Ovarian Cancer</keyword>
	<keyword>Laparoscopy</keyword>
	<keyword>Neoadjuvant Chemotherapy</keyword>
	<keyword>Robotic</keyword>
	<keyword>Interval Debulking Surgery</keyword>
</DOC>